Orthocell prepares for Remplir™ commercialisation in US with two executive appointments
Orthocell prepares for Remplir™ commercialisation in US with two executive appointments
Nov 10, 2024
proactiveinvestors.com
Just the Facts: Orthocell submits US FDA application for Remplir nerve repair product
Just the Facts: Orthocell submits US FDA application for Remplir nerve repair product
Dec 18, 2024
proactiveinvestors.com.au
Just the Facts: Orthocell achieves FDA study milestone for Remplir™ nerve repair product
Just the Facts: Orthocell achieves FDA study milestone for Remplir™ nerve repair product
Dec 1, 2024
proactiveinvestors.com.au
Just The Facts - Orthocell accelerates US rollout of Remplir in US$1.6B nerve repair market
Just The Facts - Orthocell accelerates US rollout of Remplir in US$1.6B nerve repair market
9 months ago
proactiveinvestors.com
Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?
Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?
10 months ago
hotcopper.com.au
Orthocell's Remplir hits 90% success rate
Orthocell's Remplir hits 90% success rate
3 weeks ago
proactiveinvestors.com
Orthocell surges on receiving Australian regulatory approval for Remplir™ nerve repair device
Orthocell surges on receiving Australian regulatory approval for Remplir™ nerve repair device
Mar 21, 2022
proactiveinvestors.com
Orthocell submits FDA application for Remplir™ with eye on “largest healthcare market in the world”
Dec 18, 2024
proactiveinvestors.com
Orthocell's Remplir FDA Clearance 'Major Milestone', Says Euroz Hartleys
Apr 7, 2025
marketscreener.com
Orthocell's Remplir™ delivers nerve repair in Ukraine combat trauma
2 months ago
proactiveinvestors.com.au
Orthocell receives TGA approval for first Australian-made collagen nerve repair membrane, Remplir™
Mar 21, 2022
proactiveinvestors.com.au
Orthocell records first Canadian sales of Remplir™ in US$75m market
3 weeks ago
proactiveinvestors.com
Orthocell’s nerve repair device gains Aussie momentum
8 months ago
proactiveinvestors.com.au
FDA approval sees Orthocell’s Remplir enter multi-billion dollar US nerve market
Apr 6, 2025
proactiveinvestors.com.au
Orthocell submits regulatory application for commercial distribution of Remplir
5 months ago
marketscreener.com
9 News | FDA Grants 510(k) Clearance for Remplir Nerve Product | Orthocell Ltd
4.5K views4 months ago
linkedin.com
Orthocell on course to penetrate US market following nerve repair treatment Remplir™ study phase
Mar 25, 2024
proactiveinvestors.com.au
5:00
Captain Valerio on Orthocell's nerve repair device Remplir
148 views11 months ago
YouTubeStockhead
Orthocell study shows Remplir outperforms traditional suture-only nerve repair
11 months ago
proactiveinvestors.com.au
Orthocell welcomes final "life-altering" data for nerve reconstruction study
Jun 6, 2022
proactiveinvestors.com.au
Orthocell’s nerve-repair product first sales in Singapore
Dec 12, 2024
goldcoastbulletin.com.au
Orthocell has strategy validated with A$17 million raised to fund US launch of Remplir™ and drive commercialisation
Oct 30, 2024
proactiveinvestors.com
1:26
OCC Orthocell First US Military Remplir Surgery
1 month ago
YouTubeStockWire X | ASX News
5:58
Orthocell's Remplir hits 90% success rate
652 views3 weeks ago
YouTubeProactive Investors
Orthocell sets new benchmark in nerve repair
11 months ago
theaustralian.com.au
Break it Down: Orthocell raises $30m to fast-track US rollout of Remplir nerve-repair tech | Stockhead
7 months ago
stockhead.com.au
1:33
Just The Facts - Orthocell accelerates US rollout of Remplir in US$1.6B nerve repair market
401 views9 months ago
YouTubeProactive Investors
Orthocell poised for revenue uplift following FDA clearance for Remplir™
Apr 13, 2025
proactiveinvestors.com.au
0:35
Remplir boosts Orthocell’s US market potential
88 views6 months ago
YouTubeProactive Investors
Orthocell passes commercialisation milestone with first Remplir™ sales in Singapore
Dec 11, 2024
proactiveinvestors.com.au
See more
Static thumbnail place holder